Novartis strikes deal with Danish region
Swiss drug giant Novartis has put pen to paper on a new five-year partnership with the Capital Region of Denmark. The deal is a part of a wider focus on the Danish market for Novartis.
BY STEFAN SINGH KAILAY
Thursday marked the beginning of a major focus on the Danish market for Swiss drug group Novartis, as the company signed a framework agreement with the Capital Region of Denmark set to run for the next five years.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
